As the industry leader in providing solutions for RNA research and drug development success, Eclipsebio is dedicated to sponsoring events to that bring together world experts to share their latest discoveries while also supporting the career development of junior scientists.
Eclipsebio is proud to announce our sponsorship of the 2025 Gordon Research Conference on Decoding Microproteins Across Evolution and Disease in Barcelona. This conference will include discussions on the translation of small open reading frames (ORFs) and the role of micropeptides in disease and therapeutic development.
If you are interested in making your own discoveries with our comprehensive solutions for therapeutic development or academic research, contact our team of RNA experts today.
Latest news
Eclipsebio expands its RNA characterization capabilities with multi-attribute nanopore-based sequencing assay eSTRAND RNA QC™
eSTRAND RNA QC uses direct RNA sequencing to provide multiple critical quality attributes in a single run without requiring reverse transcription or translation.
Wacker Biotech and Eclipsebio Announce Strategic Collaboration to Advance RNA Medicine Development and Production
The collaboration will combine Wacker Biotech's large-scale, GMP-compliant manufacturing with Eclipsebio's AI-driven RNA design and sequencing-based characterization for best-in-class end-to-end RNA therapeutic development support.
RNA Delivery Prato 2026
Eclipsebio is proud to sponsor the 2026 RNA Delivery Prato meeting to discuss recent discoveries and challenges in RNA delivery.
Eclipsebio Expands eCOMPASS™ Platform with eSENSE Break™ to Map RNA Fragmentation at Nucleotide Resolution
Eclipsebio's eSENSE Break uses sequencing-based analytics to map RNA fragmentation and circular RNA nicking sites at single-nucleotide resolution.